3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
6
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Cardiovascular Diseases
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Intraepithelial Neoplasia
1
Osteoporosis
1
Neuralgia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Motor Activity
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Eye Diseases
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Bone Diseases, Metabolic
1
Blast Crisis
1
Interventions
beta Carotene
1
Vitamin E
1
Geritol
1
Biopsy
1
Ascorbic Acid
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Eye Diseases
×
Geritol
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled